Steve Satek, MBA

President and Founder

Steve brings more than 25 years of research experience to Great Lakes Clinical Trials. He began his career as a bench researcher at the Northwestern University Robert H. Lurie Cancer Center and since that time has held senior management positions at the Chicago Center for Clinical Research, Radiant Research, Cognitive Drug Research and Forenap Pharma.  Just prior to opening Great Lakes Clinical Trials, Steve served as the Senior Vice President for a nationally-recognized consulting group, where he specialized in the design, implementation, and management of central nervous system and clinical pharmacology research programs.  In that role, he worked exclusively with 12 clinical pharmacology sites and 22 late phase research clinics across the U.S., which focused in the conduct of complex psychiatric and neurological trials.

Steve offers a diverse and thorough knowledge of clinical trial operations, which has been presented at over 20 industry conferences.  In addition, he has project managed and/or coordinated over 100 trials.  He holds two Bachelor of Science degrees in Molecular Biology and in Biochemistry from the University of Wisconsin-Madison and an Executive MBA from the Lake Forest Graduate School of Management. 

Jeffrey Ross, MD  

Medical Director

Dr. Jeff Ross is a board-certified psychiatrist who has conducted over 130 clinical trials across multiple disease areas including mood, anxiety, psychotic, cognitive (Alzheimer’s, MCI), sleep and substance abuse disorders. As an instructor of medical students and psychiatry residents at Chicago-area institutions (Northwestern University Medical School, Rush Medical College, Evanston Hospital, Illinois College of Optometry) over the past 20 years, Dr. Ross has provided ongoing medical education in both psychopharmacology and psychotherapy, equipping new physicians with important insights into the interviewing, care, & long-term management of patients with psychiatric illness.

Following his post-graduate fellowship in clinical psychopharmacology at Rush-Presbyterian-St.Luke’s Medical Center, Dr. Ross served as Medical Associate at Rush’s Treatment Research Center and Attending Psychiatrist at Rush-Presbyterian-St. Luke’s Medical Center, as well as Assistant Professor of Psychiatry Rush Medical College. As a board-certified psychiatrist, Dr. Ross maintains licensure in Illinois and continues to maintain his affiliation with the aforementioned academic centers. In addition, Dr. Ross’ private practice enables him to remain connected to the real world management of psychiatric illness.

From his extensive research experience, Dr. Ross has gained expertise in investigations across development phases (Phase I-IV), treatment settings (inpatient and outpatient), duration (short and long-term), trial design (open, blinded, acute therapy, relapse prevention), and intervention (psychotherapy and psychopharmacology). Aside from numerous peer-reviewed publications and lectures, Dr. Ross has also developed a particular niche providing psychiatric educational book reviews (Doody’s Health Sciences) for over a decade.

LInda Rice, PhD,


Dr. Linda Rice is a Clinical Neuropsychologist with over 25 years of clinical, management and teaching experience.  She is a Diplomat of the American Board of Professional Psychology with a Clinical Neuropsychology Specialty.  Dr. Rice earned her PhD from Loyola University in Chicago, with an Internship at The Johns Hopkins University School of Medicine in Baltimore, Maryland and a Fellowship at the Sheppard & Enoch Pratt Hospital in Baltimore, Maryland.  She is currently enrolled in a Masters of Science program in Psychopharmacology at New Mexico State University.

Dr. Rice’s teaching experience includes an appointment on the Core Faculty at the Adler University in Chicago, overseeing the Military Psychology Track and Neuropsychology Concentration in the Doctor of Clinical Psychology Program.   Dr. Rice supervised advanced graduate students in the Neuropsychology Practicum, with the mission to provide neuropsychological services to underserved communities. Clinical supervision includes assessment of a wide variety of referrals from varied socioeconomic, ethnic, and cultural backgrounds. Common referral questions for these cases include differential diagnosis and treatment recommendations for traumatic brain injury, learning disorders/ADHD, seizure disorders, multiple sclerosis, psychiatric disorders, Alzheimer’s disease and other neurological disorders and dementia.

Dr. Rice developed her experience in Alzheimer’s disease assessment as a Neuropsychologist at the Sheppard & Enoch Pratt Hospital, in Towson, Maryland from 2000-2011.  As a consultant for the comprehensive Geriatric Service, she worked collaboratively to implement discharge planning that maximized appropriate care for dementia patients including consideration of caretaker needs.  She provided training and administration of CDR and ADAS-COG, and provided assessment of dementia and family education about coping with and managing dementia cognitive and behavioral issues. 

Additional specialties include:

  • Neuropsychological assessment of children and adults with Attention Deficit Hyperactivity Disorder and Learning Disorders at the Chesapeake ADHD Center of Maryland where she studied under Kathleen Nadeau, PhD, a nationally-recognized expert in the field.
  • Service Chief at the National Naval Medical Center in Bethesda, MD where she managed the hospital’s neuropsychology assessment clinic and provided neuropsychological assessment to referrals from the inpatient services and outpatient clinics.  Dr. Rice also provided cognitive rehabilitation for TBI patients in Wounded Warriors Program.
  • Providing Initial Assessment, Neuropsychological Assessment, and Cognitive Rehabilitation of patients on the Brain Injury Unit and general rehabilitation services at the Rehabilitation Institute of Chicago

Kevin C. Maki, PhD

Investigator, Nutrition and Metabolic Disorders

Dr. Maki is the Founder and Chief Science Officer for the MB Clinical Research (formerly Midwest Center for Metabolic and Cardiovascular Research) and serves as Investigator/Consultant on Great Lakes Clinical Trials' nutrition and metabolic research trials. He specializes in the design and conduct of clinical studies in human nutrition, metabolism and chronic disease risk factor management.

Dr. Makiholds an Adjunct Faculty position in Biostatistics and Applied Epidemiology at DePaul University. He is a certified Clinical Lipid Specialist and a Fellow of the National Lipid Association, The Obesity Society and the American College of Nutrition, as well as a member of the Board of Governors of the Accreditation Council for Clinical Lipidology. Dr. Maki has participated in more than 250 clinical trials and observational studies as an investigator, consultant or statistician, and published more than 200 scientific papers, books and book chapters. He earned a Ph.D. in Epidemiology from the University of Illinois at Chicago’s School of Public Health, and an M.S. in Preventive and Rehabilitative Cardiovascular Health from Benedictine University.